Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells B Zhang, J Sun, Y Wang, D Ji, Y Yuan, S Li, Y Sun, Y Hou, P Li, L Zhao, ... Nature biomedical engineering 5 (11), 1288-1305, 2021 | 51 | 2021 |
Efficient Inhibition of SARS‐CoV‐2 Using Chimeric Antisense Oligonucleotides through RNase L Activation X Su, W Ma, D Feng, B Cheng, Q Wang, Z Guo, D Zhou, X Tang Angewandte Chemie 133 (40), 21830-21835, 2021 | 27 | 2021 |
Discovery of pentacyclic triterpenoid PROTACs as a class of effective hemagglutinin protein degraders H Li, S Wang, W Ma, B Cheng, Y Yi, X Ma, S Xiao, L Zhang, D Zhou Journal of Medicinal Chemistry 65 (10), 7154-7169, 2022 | 23 | 2022 |
Photoswitchable CAR-T cell function in vitro and in vivo via a cleavable mediator B Zhang, Y Wang, S Huang, J Sun, M Wang, W Ma, Y You, L Wu, J Hu, ... Cell Chemical Biology 28 (1), 60-69. e7, 2021 | 19 | 2021 |
An engineered influenza virus to deliver antigens for lung cancer vaccination D Ji, Y Zhang, J Sun, B Zhang, W Ma, B Cheng, X Wang, Y Li, Y Mu, H Xu, ... Nature biotechnology 42 (3), 518-528, 2024 | 13 | 2024 |
Rhodamine B-based fluorescent probes for molecular mechanism study of the anti-influenza activity of pentacyclic triterpenes M Li, L Yuan, Y Chen, W Ma, F Ran, L Zhang, D Zhou, S Xiao European Journal of Medicinal Chemistry 205, 112664, 2020 | 12 | 2020 |
Influenza virus precision diagnosis and continuous purification enabled by neuraminidase-resistant glycopolymer-coated microbeads G Li, W Ma, J Mo, B Cheng, S Shoda, D Zhou, XS Ye ACS Applied Materials & Interfaces 13 (39), 46260-46269, 2021 | 4 | 2021 |
Synthesis of novel pentacyclic triterpenoid derivatives that induce apoptosis in cancer cells through a ROS-dependent, mitochondrial-mediated pathway B Cheng, X Chu, R Liu, X Ma, M Wang, J Zhang, P Jiao, Q Gao, W Ma, ... Molecular Pharmaceutics 20 (1), 701-710, 2022 | 3 | 2022 |
疫苗研发: 新技术应获更多重视 马闻箫, 北京大学药学院, 马闻箫, 程博洋, 周德敏 前沿科学, 56-62, 2020 | | 2020 |
活病毒直接转化为预防, 治疗双功能疫苗研究进展 周雪莹, 马闻箫, 周德敏 中国科学基金 5, 2018 | | 2018 |
Efficient Inhibition of SARS‐CoV‐2 Using Chimeric oligonucleotides through RNase L Activation X Su, W Ma, D Feng, B Cheng, Q Wang, Z Guo, D Zhou, X Tang Angewandte Chemie, 0 | | |